Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Phase One Medical Announces Second Patent Issuance For Their Distal Locking Hemodialysis Catheter System

December 13, 2011 5:23 am | News | Comments

HINGHAM, Mass.--(BUSINESS WIRE)--Phase One Medical, L.L.C. a privately held medical device research and development company announced today that the U.S. Patent and Trademark Office has issued a second patent covering their Distal Locking Hemodialysis Catheter Technology.

Nonin Medical GO2 Finger Pulse Oximeter to be Featured on The Balancing Act TV Show on Lifetime Television

December 12, 2011 3:40 pm | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Dec. 12, 2011 /- Nonin Medical, Inc., the inventor of finger pulse oximetry and a leader in noninvasive medical monitoring, today announced that the GO2™ Personal Finger Pulse Oximeter will be featured on "The Balancing Act" TV Show on Lifetime Television,...

Bluegrass Vascular Technologies Begins First Clinical Study of the Surfacer Inside-Out Access Catheter System

December 12, 2011 4:23 am | News | Comments

LEXINGTON, Ky.--(BUSINESS WIRE)--Bluegrass Vascular Technologies, a medical technology company focused on life-saving devices and methods for vascular access procedures, has announced patient enrollment in the first clinical study of its Surfacerâ„¢ Inside-Out Access Catheter System...


FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac Resynchronization Therapy with Defibrillator (CRT-D) Devices

December 9, 2011 5:35 am | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices Advisory Panel determined that the overall clinical benefits of Medtronic cardiac resynchronization therapy...

COMPAS Trial Results Demonstrate the Safety and Efficacy of Daily Remote Monitoring with BIOTRONIK Home Monitoring in Pacemaker Patients

December 8, 2011 4:42 am | News | Comments

BERLIN--(BUSINESS WIRE)--BIOTRONIK today announced the publication of the COMPAS clinical trial results in the European Heart Journal1. COMPAS is the first large-scale, prospective, multi-center, randomized clinical trial to demonstrate the safety and efficacy of remote monitoring...

Cook Medical is Awarded New Contract with Novation for Cook Central Venous Catheters

December 5, 2011 4:24 am | News | Comments

Bloomington, Ind., December 5, 2011 – Beginning January 1, 2012, Cook Medical's central venous catheters (CVCs) will be available to the members served by Novation, the supply contracting company for more than 30,000 members of VHA Inc., UHC, and Provista. This expands nationwide access...

Covidien's Embolic Protection Device Receives FDA Clearance

December 2, 2011 4:35 am | News | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has cleared SpiderFX® for the treatment of severely calcified lesions used in conjunction with plaque excision...

St. Jude Medical Announces FDA Approval of Industry's First Quadripolar Pacing System

December 1, 2011 6:07 am | News | Comments

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc., a global medical device company, today announced it has received U.S. Food and Drug Administration (FDA) approval of its Unify Quadra® cardiac resynchronization therapy defibrillator (CRT-D) and Quartet® Left Ventricular Quadripolar Pacing Lead.


Emboline receives U.S. allowance for key piece of its seminal patent portfolio of aortic embolic protection technologies for percutaneous heart valve procedures such as TAVR

December 1, 2011 5:54 am | News | Comments

FREMONT, Calif.--(BUSINESS WIRE)--Emboline, Inc., an emerging medical device company, has received Notice of Allowance from the United States Patent and Trademark Office (USPTO) related to its aortic embolic protection devices for percutaneous heart valve repair and replacement.

CardioDx Blood-Based Gene Expression Test Demonstrates Superior Performance to Myocardial Perfusion Imaging to Rule Out Obstructive Coronary Artery Disease

November 17, 2011 5:39 am | News | Comments

PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, a pioneer in the field of cardiovascular genomic diagnostics, announced results of its COMPASS (Coronary Obstruction Detection by Molecular Personalized Gene Expression) trial, which were presented today at the American Heart Association Scientific Sessions...

Defibtech to Show New Lifeline PRO AED at Medica 2011

November 17, 2011 5:23 am | News | Comments

DUSSELDORF, Germany--(BUSINESS WIRE)--Defibtech will demonstrate its new Lifeline PRO automated external defibrillator (AED) at Medica 2011, Nov. 16-19, in Dusseldorf, Germany. The Lifeline PRO provides professional responders with full manual control over shock energy and shock delivery.

Gore Receives FDA Approval for Conformable GORE TAG Thoracic Endoprosthesis

November 17, 2011 5:21 am | News | Comments

FLAGSTAFF, Ariz. & NEW YORK--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) announced that it has received approval from the US Food and Drug Administration (FDA) to market the Conformable GORE® TAG® Thoracic Endoprosthesis as a minimally invasive treatment for patients...

TandemHeart Included in New Treatment Guidelines

November 17, 2011 5:14 am | News | Comments

PITTSBURGH--(BUSINESS WIRE)--The TandemHeart circulatory support system has been added to the 2011 treatment guidelines coauthored by the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA) and the Society for Cardiovascular Angiography & Interventions (SCAI).


Clinical Trial Shows Berlin Heart's EXCOR® Pediatric Ventricular Assist Device (VAD) Successfully Bridged 90% of Children with Severe Heart Failure Who Were Waiting for a Heart Transplant

November 17, 2011 5:07 am | News | Comments

THE WOODLANDS, Texas & BERLIN--(BUSINESS WIRE)--The Berlin Heart Group announced today that clinical trial data were presented this morning at the “Scientific Sessions 2011” annual meeting of the American Heart Association (AHA). These data showed that, in a clinical trial...

Therix Medical Spins Out Bluegrass Vascular Technologies, Developer of the Surfacer Inside-Out Access Catheter System

November 16, 2011 5:21 am | News | Comments

LEXINGTON, Ky.--(BUSINESS WIRE)--Medical technology incubator Therix Medical has announced the launch of spin-out Bluegrass Vascular Technologies, a stand-alone company dedicated to developing and commercializing life-saving devices and methods that address shortcomings in vascular access procedures.

BIOTRONIK Announces Six-Month Coronary Stenting ENERGY Registry Results Presented at TCT 2011

November 15, 2011 5:59 am | News | Comments

BUELACH, Switzerland--(BUSINESS WIRE)--BIOTRONIK AG announced that the six-month results of the ENERGY Registry were presented last week by Prof. Raimund Erbel at the Transcatheter Cardiovascular Therapeutics (TCT 2011) conference. This all-comers registry is investigating...

Toshiba's Cardiovascular Systems Make Transradial Approach Easier and Safer

November 15, 2011 5:56 am | News | Comments

TUSTIN, Calif.--(BUSINESS WIRE)--Performing cardiac catheterizations through the radial artery is proven to make exams safer for patients while frequently reducing post-procedure hospital stay times. To conduct radial interventions from both the right and left side, Harrison Medical Center in Bremerton, Wash...

BioVentrix Completes Enrollment in Pilot Human Clinical Trial of the PliCath HFâ„¢ Heart Failure Treatment System

November 15, 2011 5:39 am | News | Comments

SAN RAMON, Calif.--(BUSINESS WIRE)--BioVentrix, developer of the PliCath HF™ System, today announced the achievement of a significant milestone – completion of enrollment in its pilot human clinical trial. PliCath HF is a novel device which enables Epicardial Catheter-based Ventricular Restoration (ECVR).

ZOLL LifeVest Wearable Defibrillator Highly Cost-Effective Therapy

November 15, 2011 5:32 am | News | Comments

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NASDAQ GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that data showing the cost-effectiveness of the LifeVest® Wearable Defibrillator was presented...

DSM ComfortCoat® Hydrophilic Coating Utilized in New Drug Eluting Stent Delivery System from CID SpA

November 15, 2011 5:06 am | News | Comments

BERKELEY, Calif.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials science, today announced the use of its ComfortCoat® hydrophilic coating on the delivery system of CID SpA's new Cre8™ Drug Eluting Stent (DES), CE marked the 16th of July 2011.

Positive Clinical Study Results for BSP's HyperQ Technology will be reported in American Journal of Cardiology

November 15, 2011 4:56 am | News | Comments

Tel - Aviv, November 14, 2011 - BSP Biological Signal Processing Ltd. (BSP) (TASE: BSP), which develops and manufactures products for the non-invasive, accurate diagnosis of Coronary Artery Disease (CAD), recently announced the successful completion of a comprehensive clinical research study...

Leadless pacemaker brings new hope to cardiac patients

November 15, 2011 4:50 am | News | Comments

Cambridge, MA and UK– November 14, 2011 – Cambridge Consultants, a leading technology design and development firm, today unveiled how it has collaborated with start-up company EBR Systems to develop the world's first wireless pacing system. With cardiac stimulation leads...

North Carolina Medicaid Issues Favorable Policy on ZOLL LifeVest Wearable Defibrillator

November 14, 2011 5:45 am | News | Comments

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NASDAQ GS: ZOLL), the manufacturer of the LifeVest® Wearable Defibrillator, announced today that North Carolina's Division of Medical Assistance has established a coverage policy for wearable cardioverter defibrillators.

New Data Confirms Early Implantation of Impella 2.5 Prior to PCI Improves Survival in Shock Patients

November 14, 2011 5:31 am | News | Comments

DANVERS, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced new results from a multicenter retrospective study demonstrating that early initiation of support with Impella® 2.5...

Neovasc Inc. Receives CE Mark for Reducer Product to Treat Refractory Angina

November 14, 2011 5:17 am | News | Comments

November 14, 2011 - Vancouver, BC, Canada - Neovasc Inc. (TSXV: NVC), today announced that it has received the CE mark designation for its Reducerâ„¢ product for the treatment of refractory angina. CE marking confirms that the Reducer conforms to the applicable European Directive...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.